Contact the media relations team
mediarelations@bmj.com
+44 (0)7825 118 107
+44 (0)7388 708 030
Media hub
Stem cell therapy can safely slow progression of relapsing-remitting MS
2024-06-04T10:24:03+00:0026 September 2023|Journal of Neurology Neurosurgery and Psychiatry, Press release|Physical health|